With an eye on the oncology space, Israeli startup Medial EarlySign has inked a deal with pharma giant Roche Diagnostics International to commercialize an artificial intelligence tool that helps detect cancer early. As part of the collaboration agreement, the pair will develop, clinically validate and then commercialize the product.
Initially the companies will focus on the gastric cancer space...
Roche Diagnostics India has introduced a mobile app that supports the emotional wellbeing of healthcare professionals amid the ongoing COVID-19 pandemic.
WHAT IT DOES
According to a press statement, REACH provides healthcare workers access to counselling sessions and self-help content through videos and articles. The app also features self-assessment tools on work-related challenges, parenting...
One of the GCC’s largest integrated healthcare service providers has partnered with Roche Diagnostics to transform its diagnostic solutions across its hospitals, clinics, and laboratories, it has been announced.
This week, Aster DM Healthcare signed a Memorandum of Understanding (MoU) with the Swiss multinational to transform “Aster’s existing systems into a single platform with the latest state-...
Driving digital diagnosis. Roche and Israeli life sciences investment firm aMoon announced plans this week to launch an early-stage investment program called StarFinder Lab. Focused on novel diagnostic technologies, in particular, with the help of AI data analysis and digital health tools, the program will provide funding, mentoring and other strategic support such as a physical office space...
Roche Diagnostics has launched a Bluetooth-connected device for testing blood coagulation in Europe. The CoaguChek INRange system has received a CE Mark, and an older version of the device without the Bluetooth connectivity is already available in the US and in Europe.
The Bluetooth connectivity allows patients undergoing Vitamin K antagonist therapy to self-monitor their blood coagulation with a...
French companion app company Voluntis has partnered with AstraZeneca to develop an app for women undergoing treatment for ovarian cancer. Specifically, the app will help patients and clinicians manage the side effects of a combination therapy of the drugs cediranib and olaparib, which can cause hypertension and diarrhea.
"AstraZeneca has a strong focus on the use of companion devices in drug...
Voluntis's Diabeo app, not available in the United States
French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer.
Voluntis makes companion apps as medical devices. It has so far focused on the areas of diabetes, hemophilia, and coagulation. Voluntis actually worked with Roche Diagnostics in the past...
Pictured above: A device from Cambridge-based MC10, a company focused on flexible electronics.
The US Department of Defense is making a big bet on flexible electronics, an area of technology with close ties to mobile health. The DoD announced last week that it will invest $75 million in a public-private partnership called the Manufacturing Innovation Institute for Flexible Hybrid Electronics,...
Less than a month after announcing its partnership with Novartis, Qualcomm is adding another big pharmaceutical company to its list of 2net partners: Roche, who will use Qualcomm Life's 2net platform to capture patient data from connected devices, starting with anti-coagulation meters.
“This collaboration marks a significant milestone for Roche as we launch a new generation of point-of-care...
Diabetes management tools just got a step closer to medical device interoperability.
A few hours after news broke that A&D Medical's Bluetooth-enabled blood pressure cuff and Bluetooth-enabled weight scale had received Continua Health Alliance's stamp of interoperability, the organization announced that Roche Diagnostics' Accu-Chek Smart Pix Device Reader, which currently interfaces with...
